tiprankstipranks
Trending News
More News >

Adagio Medical Holdings CFO Resignation Announced

Story Highlights
Adagio Medical Holdings CFO Resignation Announced

Confident Investing Starts Here:

Adagio Medical Holdings ( (ADGM) ) has shared an update.

On March 11, 2025, John Dahldorf, CFO of Adagio Medical Holdings, announced his resignation effective March 21, 2025. His departure was not due to any disagreements with the company, and a search for his replacement is underway. The company is advancing its focus on ventricular tachycardia solutions, with participation in the 2025 European Heart Rhythm Association Annual Meeting and progress in its FULCRUM-VT IDE Pivotal Study, which is over 40% enrolled. CEO Todd Usen expressed confidence in the company’s ability to meet its goals and thanked Dahldorf for his contributions.

More about Adagio Medical Holdings

Adagio Medical Holdings, Inc. is an early commercial stage medical device company based in Laguna Hills, California, specializing in the development of proprietary Ultra-Low Temperature Cryoablation technology for treating cardiac arrhythmias, with a focus on ventricular tachycardia.

YTD Price Performance: -7.69%

Average Trading Volume: 531,456

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $16.61M

For detailed information about ADGM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App